[ Price : $8.95]
FDA awards a $675,000 grant to the Critical Path Institute to allow scientists to evaluate genetic tests for determining existing ...[ Price : $8.95]
FDA issues Uroplasty, Inc. an approvable letter for its PMA on Macroplastique implants intended to treat female stress urinary inc...[ Price : $8.95]
A scathing FDA untitled letter provides a glimpse into the troubles contract research organization MDS Pharma is having in trying ...[ Price : $8.95]
A new FDA guidance outlines responsibilities for firms to comply with current good tissue practice requirements when they enter in...[ Price : $8.95]
CDERs Joseph Famulare cites recent statistics on drug recalls, and identifies specific problem areas in production and quality sys...[ Price : $8.95]
FDA plans a follow-up inspection of a Medtronic neurological devices manufacturing facility after the agency received limited info...[ Price : $8.95]
Retired FDA chemist Burton Appleton asks USP to help him appeal last months federal court loss to FDA on levothyroxine documents, ...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Actavis Totowa, Frye Health Systems, Hamricks, LGS Technologies, Medtronic, and ...